Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Christina Kurre Olsen"'
Publikováno v:
Journal of Affective Disorders. 250:35-42
Background Residual cognitive symptoms in major depressive disorder (MDD) are common, yet poorly investigated. We explored the effectiveness of vortioxetine as adjunctive treatment to selective serotonin reuptake inhibitors (SSRI) and as monotherapy
Publikováno v:
Journal of Affective Disorders. 227:803-809
Background Major Depressive Disorder (MDD) is a heterogeneous disease characterized by emotional, physical and cognitive symptoms. This study explored the effects of vortioxetine versus escitalopram on outcomes of cognition, functioning and mood symp
Autor:
William Jacobson, Christina Kurre Olsen, Wei Zhong, Michael Cronquist Christensen, Philip D. Harvey, George G. Nomikos
Publikováno v:
Current medical research and opinion. 36(1)
Objective: To evaluate the consistency of vortioxetine’s effects on functional capacity in adults with major depressive disorder (MDD) and self-reported cognitive symptoms at different leve...
Autor:
Maurizio, Fava, Atul R, Mahableshwarkar, William, Jacobson, Wei, Zhong, Richard Se, Keefe, Christina Kurre, Olsen, Judith, Jaeger
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 30(3)
Cognitive impairments, such as memory deficits and executive impairment, are common among patients with major depressive disorder (MDD) and can be captured with objective or subjective assessments. The aim of this post-hoc analysis of the CONNECT stu
Autor:
Elena Dale, Connie Sanchez, Theepica Jeyarajah, Gennady N. Smagin, Steven C. Leiser, Yan Li, Alan L. Pehrson, Christina Kurre Olsen
Publikováno v:
CNS Spectrums
The hippocampus plays an important role in emotional and cognitive processing, and both of these domains are affected in patients with major depressive disorder (MDD). Extensive preclinical research and the notion that modulation of serotonin (5-HT)
Publikováno v:
Journal of affective disorders. 229
Background Major Depressive Disorder (MDD) is a complex disease characterized by emotional, physical and cognitive symptoms. We explored the efficacy of vortioxetine versus placebo on outcomes of cognition, functioning and mood symptoms in working pa
Publikováno v:
The International Journal of Neuropsychopharmacology
The efficacy of vortioxetine 10 and 20 mg/d vs. placebo on cognitive function and depression in adults with recurrent moderate-to-severe major depressive disorder (MDD) was evaluated. Patients (18–65 yr, N = 602) were randomized (1:1:1) to vortioxe
Autor:
George G. Nomikos, Christina Kurre Olsen, Philip D. Harvey, Wei Zhong, Elizabeth Merikle, William Jacobson, Michael Cronquist Christensen
Publikováno v:
Journal of affective disorders. 213
Background This article reports an evaluation of the psychometric properties and clinically important difference (CID) threshold of the UCSD Performance-Based Skills Assessment (UPSA) in major depressive disorder (MDD), using data from a large-scale
Publikováno v:
International Clinical Psychopharmacology. 27:215-223
The efficacy and tolerability of Lu AA21004 at 5 mg/day, a novel multimodal antidepressant, were assessed in elderly patients with recurrent major depressive disorder. Patients were randomly assigned (1:1:1) to Lu AA21004 5 mg/day, duloxetine 60 mg/d
Publikováno v:
European Neuropsychopharmacology. 27:S797-S798